Accessibility and Inclusivity of Chimeric Antigen Receptor T-cell Immunotherapy in Treating Hematological Malignancies
Onyeka Milicent Asumah, Fadilulahi Ayokunle Usman, Chiamaka Barbara Agbaetuo, Augustine Odibo, Olabanjo Blessing Oladoyin, Chimaobi Jude Nwiyi, Kenechukwu Eric Anthony Ujam & Oluwatosin Sunday Afolayan · Asian Journal of Advanced Research and Reports · 2024
Targeting the molecule cluster of differentiation 19 (CD19), chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell therapy now used in clinical practice for hematological malignancies. Studies on CAR-T-cell therapy have shown that it is highly effective, wit...
Open access
Research Article
10.9734/ajarr/2024/v18i11777